36. Rioja I, Bush KA, Buckton JB, Dickson MC, Life PF (2004) Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol 137: 65–73. 37. Kijima K, Toyosawa K, Yasuba M, Matsuoka N, Adachi T, et al. (2004) Gene expression analysis of the rat testis after treatment with di(2-ethylhexyl) phthalate using cDNA microarray and real-time RT-PCR. Toxicology and Applied Pharmacology 200: 103–110. 38. Gao Y, Deng J, Yu XF, Yang DL, Gong QH, et al. (2011) Ginsenoside Rg1 inhibits vascular intimal hyperplasia in balloon-injured rat carotid artery by down-regulation of extracellular signal-regulated kinase 2. Journal of Ethno- pharmacology 138: 472–478. 39. Dijkgraaf LC, de Bont LG, Boering G, Liem RS (1995) The structure, biochemistry, and metabolism of osteoarthritic cartilage: a review of the literature. J Oral Maxillofac Surg 53: 1182–1192. 40. Darby IA, Hewitson TD (2007) Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 257: 143–179. 41. Lee CH, Shah B, Moioli EK, Mao JJ (2010) CTGF directs fibroblast differentiation from human mesenchymal stem/stromal cells and defines connective tissue healing in a rodent injury model. J Clin Invest 120: 3340–3349. 42. Shen G, Darendeliler MA (2005) The adaptive remodeling of condylar cartilage–-a transition from chondrogenesis to osteogenesis. J Dent Res 84: 691–699. 43. Gruber HE, Gregg J (2003) Subchondral bone resorption in temporomandibular joint disorders. Cells Tissues Organs 174: 17–25. 44. Beek M, Koolstra JH, van Ruijven LJ, van Eijden TM (2001) Three-dimensional finite element analysis of the cartilaginous structures in the human temporo- mandibular joint. J Dent Res 80: 1913–1918. 45. Tanaka E, Detamore MS, Mercuri LG (2008) Degenerative disorders of the temporomandibular joint: etiology, diagnosis, and treatment. J Dent Res 87: 296–307. 46. Takahashi T, Nagai H, Seki H, Fukuda M (1999) Relationship between joint effusion, joint pain, and protein levels in joint lavage fluid of patients with internal derangement and osteoarthritis of the temporomandibular joint. J Oral Maxillofac Surg 57: 1187–1193; discussion 1193–1184. MIA Induced TMJOA in Rat 47. Schmitter M, Wacker K, Pritsch M, Giannakopoulos NN, Klose C, et al. (2010) Preliminary longitudinal report on symptom outcomes in symptomatic and asymptomatic women with imaging evidence of temporomandibular joint arthritic changes. Int J Prosthodont 23: 544–551. 48. Campos MI, Campos PS, Cangussu MC, Guimaraes RC, Line SR (2008) Analysis of magnetic resonance imaging characteristics and pain in temporo- mandibular joints with and without degenerative changes of the condyle. Int J Oral Maxillofac Surg 37: 529–534. 49. Im HJ, Kim JS, Li X, Kotwal N, Sumner DR, et al. (2010) Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum 62: 2995–3005. 50. Hashimoto S, Setareh M, Ochs RL, Lotz M (1997) Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum 40: 1749–1755. 51. Chagin AS, Karimian E, Zaman F, Takigawa M, Chrysis D, et al. (2007) Tamoxifen induces permanent growth arrest through selective induction of apoptosis in growth plate chondrocytes in cultured rat metatarsal bones. Bone 40: 1415–1424. 52. Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, et al. (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130: 811–823. 53. Kouri-Flores JB, Abbud-Lozoya KA, Roja-Morales L (2002) Kinetics of the ultrastructural changes in apoptotic chondrocytes from an osteoarthrosis rat model: a window of comparison to the cellular mechanism of apoptosis in human chondrocytes. Ultrastruct Pathol 26: 33–40. 54. Berenbaum F (2004) Signaling transduction: target in osteoarthritis. Curr Opin Rheumatol 16: 616–622. 55. Baragi VM, Becher G, Bendele AM, Biesinger R, Bluhm H, et al. (2009) A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models. Arthritis Rheum 60: 2008–2018. 56. Sandy JD, Verscharen C (2001) Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo. Biochem J 358: 615–626. PLOS ONE | www.plosone.org 12 September 2012 | Volume 7 | Issue 9 | e45036